Zydus gets final approval from USFDA for Perphenazine Tablets USP

Zydus gets final approval from USFDA for Perphenazine Tablets USP

by admin- Tuesday, April 7th, 2020 04:07:15 PM

Zydus Cadila has obtained very last approval from the USFDA to marketplace Perphenazine Tablets USP, 2 mg, 4 mg, eight mg and sixteen mg.

This medicinal drug is indicated for the treatment of schizophrenia and for the manipulate of excessive nausea and vomiting in adults. The drug may be synthetic on the organization’s components production facility at Baddi.

The group now has 284 approvals and has up to now filed over 386 ANDAs since the graduation of the filing manner in FY 2003-04.

News Updates